期刊文献+

25-羟维生素D_3治疗2型糖尿病患者早期肾损害的临床观察 被引量:4

Clinical observation of 25-hydroxy vitamin D_3 in the treatment of early renal damage in patients with type 2 diabetes mellitus
下载PDF
导出
摘要 目的观察25-羟维生素D3(Vit D3)对2型糖尿病(T2DM)患者早期肾损害的临床疗效。方法纳入T2DM早期肾损伤患者80例,采用随机数字表法等分为治疗组与对照组,对照组继续原有降糖方案,治疗组在既往用药基础上,肌肉注射Vit D3注射液,疗程均为10个月,治疗结束后进行疗效评价。结果 1与治疗前相比,治疗组糖化血红蛋白(HbA1c)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)水平上调,微量白蛋白(MA)、β2-微球蛋白(β2-M)及肾脏损伤分子-1(KIM-1)水平下调,治疗组低于对照组差异有统计学意义(P<0.05)。2与治疗前相比,治疗组治疗后Vit D3水平上调,治疗组高于对照组差异有统计学意义(P<0.01)。3T2DM患者Vit D3水平与MA(r=-0.432),β2-M(r=-0.615),及KIM-1(r=-0.763)水平均呈负相关(P<0.05)。结论 Vit D3可有效减轻T2DM患者的早期肾损害,对肾脏具有保护作用。 Objective To observe the clinical effect of 25-hydroxy vitamin D3 (25 (OH)D3 ) on early renal damage in patients with type 2 diabetes mellitus (T2DM). Methods Eighty patients with T2DM and early renal damage were equally randomly divided into the treatment group and the control group. The control group was treated with the original antidiabetic scheme, and the treatment group was treated with the original antidiabetic scheme and intramuscular injection of vitamin D3. Both the two groups were treated for 10 months, and then we e- valuated the clinical efficacy. Results Compared with before treatment, the expression levels of hemoglobin Alc (HbAlc), total cholesterol (TC), triglyceride (TG) and low density lipoproteins (LDL-C) were increased in the treatment group, while the expression levels of micro albumin (MA), β2-microglobulin (β2-M) and kidney injury molecule-1 (KIM-1) were decreased in the treatment group. And these index in the treatment group was lower than those in the control group ( P d0. 05). Compared with before treatment, the expression level of Vit D3 was increased in the treatment group, and it was higher in the treatment group than that in the control group ( P d0.01). (~)The expression level of T2DM patientts Vit D3 were negatively correlated with MA ( r = -0. 432), β2-M ( r = -0. 615) and KIM-1 ( r =-0. 763) (P d0.05). Conclusion 25-hydroxy vitamin D3 can effectively re- duce T2DM patientrs early renal damage, which has a protective effect on the kidney.
出处 《山西医药杂志》 CAS 2016年第4期386-389,共4页 Shanxi Medical Journal
基金 唐山市科学技术研究与发展指导计划项目(121302024a)
关键词 骨化二醇 糖尿病 2型 肾功能衰竭 Calcifediol Diabetes mellitus, type 2 Kidney faliure
  • 相关文献

参考文献3

二级参考文献19

  • 1RR Little,CL Rohlfing,DB Sacks,National Glycohemoglobin Standardization Program (NGSP) Steering Committee.Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clinical Chemistry . 2011
  • 2Martin David D,Shephard Mark D S,Freeman Hayley,Bulsara Max K,Jones Timothy W,Davis Elizabeth A,Maguire Graeme P.Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community. The Medical journal of Australia . 2005
  • 3Hilton Deborah J,O’Rourke Peter K,Welborn Timothy A,Reid Christopher M.Diabetes detection in Australian general practice: a comparison of diagnostic criteria. The Medical journal of Australia . 2002
  • 4d’Emden Michael C,Shaw Jonathan E,Colman Peter G,Colagiuri Stephen,Twigg Stephen M,Jones Graham R D,Goodall Ian,Schneider Hans G,Cheung N Wah.The role of HbA1c in the diagnosis of diabetes mellitus in Australia. The Medical journal of Australia . 2012
  • 5M. Sue Kirkman,David M. Kendall.Hemoglobin A(1c) to Diagnose Diabetes: Why the Controversy over Adding a New Tool?. Clinical Chemistry . 2011
  • 6Consensus Committee.Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the Inte. Diabetes Care . 2007
  • 7Rahbar S,Blumenfeld O,Ranney H M.Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochemical and Biophysical Research Communications . 1969
  • 8Gallagher Emily Jane,Le Roith Derek,Bloomgarden Zachary.Review of hemoglobin A(1c) in the management of diabetes. Journal of diabetes . 2009
  • 9David B. Sacks.A1C Versus Glucose Testing: A Comparison. Diabetes Care . 2011
  • 10Cheung N Wah,Conn Jennifer J,d’Emden Michael C,Gunton Jenny E,Jenkins Alicia J,Ross Glynis P,Sinha Ashim K,Andrikopoulos Sofianos,Colagiuri Stephen,Twigg Stephen M.Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus. The Medical journal of Australia . 2009

共引文献6736

同被引文献49

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部